Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiloride Treatment in Multiple Sclerosis
2007-004051-11Phase 4Completed
- Sponsor
- Oxford Radcliffe Hospitals NHS Trust
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of amiloride in primary progressive multiple sclerosis (PPMS), sponsored by Oxford Radcliffe Hospitals NHS Trust. Primary endpoint: Change in MRI markers of neurodegeneration over 12 months. Started Jul 2008; status: completed.
02
Drugs
amiloride
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on 2007-004051-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004051-11.